先看重点
在前列腺癌术后漏尿的男性中,生物反馈设备辅助与治疗师指导的盆底训练,治疗成功率(漏尿减少至少50%)无差异(OR 1.19,95%CI 0.53-2.66;P=0.670),总体成功率为52.1%。研究没有不接受训练的对照组,改善不能归因于任一方法。
证据类型
随机对照试验
解读依据
公开摘要
阅读重点
对照与不确定性
研究在问什么
根治性前列腺切除术后尿失禁很常见,盆底肌训练已知有帮助。作者检验在配合12周全身高强度抗阻训练的前提下,无创生物反馈辅助设备是否比传统物理治疗师指导的训练更有效。
研究了谁,如何研究
随机对照试验,纳入因局限性前列腺癌接受根治性前列腺切除术的男性,分为设备辅助训练组(n=55)和物理治疗师指导训练组(n=54)。两组均完成12周中高负荷(>60%的一次最大重复)、做到瞬时力竭的全身抗阻训练。训练前后用24小时尿垫称重试验测量漏尿量,主要终点为治疗成功,即漏尿减少至少50%。试验为回顾性注册(NCT06206993)。
主要发现
以下为作者报告的结果。数字须连同人群和不确定性一起阅读。
- 196名参与者(88%)完成干预,24小时尿垫试验值从训练前到训练后显著下降(均值-86.39 g,SD 336.25 g;P<0.001)。
- 2治疗成功率两组无差异(OR 1.19,95%CI 0.53-2.66;P=0.670),全体参与者成功率为52.1%。
- 3在仅限成功者的事后探索性分析中,设备组漏尿相对减少幅度更大(-83.97%,SD 13.88%),物理治疗师指导组为-74.68%(SD 12.93%;P=0.017),但未做多重检验校正。
- 4术后时间越长,成功率越低(P<0.001);年龄(P=0.313)和后续康复治疗(P=0.994)无预测作用。
局限与不确定性
- 1两组接受相同的抗阻训练,且没有不做盆底训练的组,整体改善可能部分源于随时间的自然恢复。
- 2设备组占优的差异属事后探索性分析,未校正多重检验,且仅限于成功者。
- 3试验为回顾性注册,完成率为88%。
- 4只在12周项目结束时测量,持续效果未知。本解读仅基于摘要。
对日常健康的启示
这项试验中,生物反馈设备在实现明显漏尿减少上并未明确优于指导训练,两种方式可能都合理。具体选择哪种、术后何时开始,应由泌尿外科或康复团队决定。
如何联系自己的数据
这属于临床康复问题,可穿戴数据难以测量。若要记录,漏尿或尿垫使用日记以及训练日志,按相同方式连续记录几周,比设备指标更有意义。
如何理解这类证据
随机分组有助于因果推断,仍须检查分配、盲法、失访、随访时间和具体对照;标为随机试验不自动意味着高确定性。
作者的结构化摘要 English
以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。
Background
Radical prostatectomy (RP) often leads to urinary incontinence (UI). There is sufficient evidence from randomized controlled trials (RCTs) that pelvic floor muscle and sphincter training (PFMT) are effective interventions to reduce UI.
Objective
To compare the effects of high-effort resistance training (HERT) combined with a non-invasive biofeedback-assisted device PFMT (dPFMT) versus HERT combined with conventional physiotherapeutic PFMT (pPFMT) on UI in prostate cancer patients undergoing RP.
Methods
Men with a history of RP for localized prostate cancer were randomly assigned to dPFMT (n = 55) or pPFMT group (n = 54). Both PFMT intervention groups underwent a 12-week whole body HERT program performed at moderate to high loads (> 60% 1-repetition maximum, performed to momentary failure).
Measurements
Urinary leakage was assessed with the 24-hour pad weight test (24-h pad test) at the baseline (T0) and at the end of the 12-week lasting programs (T1). Individual changes of cumulative pad weight in gram (g) from T0 to T1 were calculated and compared between groups. An UI reduction of ≥ 50% was considered as treatment success and compared between groups (primary endpoint).
Results
Ninety-six participants (88%) completed the intervention. All participants demonstrated a statistically significant reduction in 24-h pad test values from T0 to T1 (Mean (SD): -86.39 g (336.25 g); 𝑝 < 0.001). Treatment success did not differ between groups (OR = 1.19, 95% CI 0.53-2.66; 𝑝 = 0.670) and was achieved by 52.1% of all participants. In a post hoc exploratory analysis restricted to participants achieving treatment success, the relative reduction in urinary leakage from T0 to T1 was greater in the dPFMT group than in the pPFMT group (mean (SD) = -83.97% (13.88%) vs. -74.68% (12.93%); 𝑝 = 0.017). This exploratory finding should be interpreted with caution, particularly because no adjustment for multiple testing was applied. Time since surgery was a significant negative predictor of treatment success (p < 0.001), whereas age (p = 0.313) and follow-up rehabilitation treatment (AHB; p = 0.994) were not. None of the examined variables predicted the magnitude of change in urinary leakage.
Conclusion
Both device-based and physiotherapist-guided PFMT were associated with significant reductions in objectively measured urinary leakage after RP. No statistically significant between-group differences were observed under conditions evaluated in this study.
Trial registration
ClinicalTrials.gov Identifier NCT06206993, retrospectively registered on 15 December 2023.
来源与署名
Non-invasive biofeedback-assisted vs. conventional pelvic floor muscle training combined with high-effort resistance training for urinary incontinence after radical prostatectomy: a randomized controlled trial.
Babović M, Aguayo D, Wiskemann J.
BMC urology · 2026-09-14
DOI: 10.1186/s12894-026-02333-9 ↗PubMed · 42754866 ↗Europe PMC · 记录的开放许可: cc by ↗摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。
MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅
来源核验日期 2026-11-01
实用健康指南
放在一起读
ACSM综述137项系统评价:抗阻训练有效,影响结果的方案细节很少
美国运动医学会汇总了137项系统评价(超过30,000名健康成年人),认为抗阻训练在力量、肌肉量、爆发力、耐力和多项功能测试上优于不运动。能一致影响结果的方案细节很少:较大负荷(不低于单次最大重复量的80%)和2至3组有利于力量,每周至少10组有利于肌肉量,而训练至力竭、器械类型和周期化则没有一致影响。它汇总的是系统评价而非新试验,没有合并效应量,所依据的多为未经训练者,且各评价所含的原始试验有重叠。
Medicine & Science in Sports & Exercise
几乎所有抗阻训练方案都优于不运动,大负荷在力量上排名居前
一项纳入随机试验的网状荟萃分析(力量网络178项研究、5097人,肌肥大网络119项研究、3364人)显示,几乎所有抗阻训练方案都优于不运动。大负荷、多组、每周至少3次的方案在力量上排名最前(标准化均数差1.60,95%可信区间1.38至1.82),大负荷、多组、每周2次的方案在肌肥大上排名最前(0.66,0.47至0.85)。多数方案之间在统计学上无法区分(91%的两两比较中95%可信区间包含零),且偏倚风险为中到高,因此排名只是初步参考。
British Journal of Sports Medicine
肌肉强化活动与更低的死亡、心血管病、癌症和糖尿病风险相关
汇总16项成年人前瞻性队列研究,进行肌肉强化活动者的全因死亡风险低15%(RR 0.85,95%置信区间0.79至0.93),心血管疾病和糖尿病风险各低17%(RR均为0.83)。全因死亡曲线在每周约40分钟时最低(RR 0.83),但更大运动量是有益还是有害尚不清楚。这些都是观察性结果,主要来自美国的自我报告数据,作者将大多数结局的证据确定性评为极低。
British Journal of Sports Medicine
蛋白补充剂配合力量训练:额外增益有限,年长者更少
汇总49项随机对照试验、1863名进行至少6周抗阻训练的健康成年人,蛋白补充剂在单纯训练的基础上使去脂体重多增加0.30 kg(95%置信区间0.09至0.52),使最大重复量力量多增加2.49 kg(0.64至4.33)。这些增量远小于训练本身的作用,年龄越大越弱,而所谓1.6 g/kg/天的平台点没有统计学意义(P=0.079)。有一位作者曾获美国国家乳制品委员会资助,该机构也资助过纳入分析的试验。
British Journal of Sports Medicine

